Gain Therapeutics Inc
Gain Therapeutics Inc (GANX) Option Chain
Read more
Tracking the GANX option chain helps you see every strike and expiry on Gain Therapeutics Inc in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of GANX options activity at a glance. Use our scanner to monitor the GANX option chain in real time and filter for the trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For GANX stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where GANX options are being actively traded, and where they are not.
Gain Therapeutics, Inc., a biotechnology company, engages in developing various therapies to treat diseases caused by protein misfolding. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancement Therapy platform to discover allosteric sites on misfolded proteins and identify proprietary small molecules that bind these sites, restore protein folding, and treat disease. It is developing structurally targeted allosteric regulator candidates to treat various diseases, including Morquio B, GM1 gangliosidosis (GM1), neuronopathic Gaucher disease, GBA1 Parkinson's, Krabbe, and Mucopolysaccharidosis type 1 diseases.
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 1.08 | 568 | 131 | 0.00 | 0.57 | 0.35 | 0.80 | 0.50 | -54.95 | — | 1.45 | 0.00 | 1.45 | 0 | 5 | 98.92 |
| 43.64 | 458 | 11 | 0.23 | 0.07 | — | 0.30 | 1.00 | -9.91 | — | 1.20 | 0.00 | 1.20 | 0 | 1 | 56.36 |
| 86.21 | 1,001 | 4 | 0.20 | 0.00 | — | 0.20 | 1.50 | +35.14 | — | 2.90 | 0.43 | 2.47 | 0 | 1,106 | 13.79 |
| 97.60 | 1,511 | 0 | 0.05 | 0.00 | — | 0.05 | 2.00 | +80.18 | 0.20 | 1.60 | 0.93 | -0.03 | 0 | 31 | 2.40 |
| 99.94 | 253 | 0 | 0.05 | 0.00 | — | 0.05 | 3.00 | +170.27 | — | 4.40 | 1.93 | 2.47 | 0 | 0 | 0.06 |
As of Nov 18, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV Rank99.60% High
- Market cap (M$)49
- 52 weeks high-74.42%
- 52 weeks low18.09%
- Analyst recommendationStrong Buy
1.00 - Target price$6.60
516.82% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-10
- P/E—
- Future P/E—
- EPS (ttm)-0.43
- EPS growth next 5 years-2.92%
As of Nov 18, 2026